News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Nina Niu Sanford: First clinical PULSAR study is out
utswmed.org
Nov 20, 2024, 19:11

Nina Niu Sanford: First clinical PULSAR study is out

Nina Niu Sanford, Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X about a recent paper by Michael Dohopolski et al. published in International Journal of Radiation Oncology, Biology, Physics:

“First clinical PULSAR study is out! Congrats Michael Dohopolski, Tu Dan, Bob Timmerman and rest of UTSW CNS team!”

“Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment”

Authors: Michael Dohopolski, Luiza Schmitt, Soummitra Anand, Tu Dan, Zabi Wardak, et al.

Nina Niu Sanford: First clinical PULSAR study is out

More posts featuring Nina Sanford.

Nina Niu Sanford is an Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital. She specializes in treating gastrointestinal cancers and actively participates in clinical trials combining high-dose radiation therapy with immunotherapy. Additionally, she researches healthcare access disparities and conducts pan-cancer outcomes research using large databases.

Bob Timmerman cancer clinical trials Luiza Schmitt Michael Dohopolski Nina Niu Sanford OncoDaily Oncology PULSAR Soummitra Anand Tu Dan UTSW Zabi Wardak
Special Coverage
Blog
Nov 20, 2024, 19:12
Medicaid Cancer Foundation at 1Ummah Annual Convention
Insight
Nov 20, 2024, 19:12
Sahar Mansour: Advancing Breast Microcalcification Detection with AI
Blog
Nov 20, 2024, 19:12
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Blog
Nov 20, 2024, 19:12
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC
Insight
Nov 20, 2024, 19:12
Nareg Varjabedian: Antidiabetic Drugs and Cancer Prevention
Insight
Nov 20, 2024, 19:12
Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer
Insight
Nov 20, 2024, 19:12
Physicians’ perspectives on cancer-related fatigue management: A cross-sectional survey study in Germany - MASCC
Insight
Nov 20, 2024, 19:12
Ajay Major: Golcadomide and R-CHOP as first line for LBCL by Arnaud Amzallag et al.
Blog
Nov 20, 2024, 19:12
Rahul Gosain: Role of diet and exercise in cancer with Neil Iyengar
Insight
Nov 20, 2024, 19:11
Nina Niu Sanford: First clinical PULSAR study is out
Blog
Nov 20, 2024, 18:33
Bernard A. Fox: R. Bryan Bell has accepted the roles of executive medical director of Providence Cancer Institute
Insight
Nov 20, 2024, 18:26
Survival Outcomes of an Early Smoking Cessation Treatment After a Cancer Diagnosis